Florencia McAllister, MD
Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2000 | National University of Rosario Medical School, Rosario, Santa Fe, ARG, MD, Medical |
Postgraduate Training
| 2014-2014 | Research Fellowship, Tumor Immunology, Johns Hopkins University Oncology Department, Baltimore, MD |
| 2009-2014 | Clinical Fellowship, Medical Oncology Fellowship, Johns Hopkins University, Oncology Department, Baltimore, MD |
| 2009-2012 | Clinical Fellowship, Clinical Pharmacology Fellowship Johns Hopkins University, Internal Medicine Department, Baltimore, MD |
| 2007-2008 | Clinical Research Certificate, Clinical Research Training Program University of Pittsburgh-School of Medicine, General Internal Medicine Department, Pittsburgh, PA |
| 2006-2008 | Clinical Residency, Internal Medicine, UPMC Presbyterian Shadyside University of Pittsburgh Medical Center Internal Medicine Department, Pittsburgh, PA |
| 2005-2006 | Clinical Internship, UPMC Presbyterian University of Pittsburgh Medical Center Internal Medicine Department, Pittsburgh, PA |
| 2003-2005 | Postdoctoral Fellowship, Immunology, Children's Hospital of Pittsburgh Immunology and Host Defense Lab, Pittsburgh, PA |
| 2002-2003 | Postdoctoral Fellowship, Louisiana State University Gene Therapy Program, New Orleans, LA |
Board Certifications
| 2015 | Medical Oncology |
| 2010 | Internal Medicine |
Experience & Service
Institutional Committee Activities
Committee Member, UT GSBS Admission Committee, 2016 - 2018
Committee Member, CCP Department Faculty Recruitment Committee, 2016 - 2023
CCP Department Representative, Infectious Disease Committee, 2015 - 2023
Honors & Awards
| 2023 | Mary Beth Maddox Award for Pancreatic Tumor Microbiome Research, Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) |
| 2022 | Faculty Scholar Award, MD Anderson Cancer Center |
| 2016 | V Foundation Scholar, V Foundation |
| 2016 | AGA Scholar, AGA |
| 2014 | AACR/PanCAN Career Development Award, AACR/PanCAN |
| 2014 | New Faculty Award, MD Anderson |
| 2013 | GI ASCO Merit Award, GI ASCO |
| 2012 | AACR Basic Science Fellowship, AACR |
| 2012 | ASCO Young Investigator Award, ASCO (CCF) |
| 2012 | T32 Training grant in Clinical Pharmacology, NIGMS |
| 2009 | O’Toole Award, University of Pittsburgh |
| 2004 | Scholarship NIAID, Tuberculosis and Pulmonary Infections Assembly |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Pudakalakatti S, Raj P, Salzillo TC, Enriquez JS, Bourgeois D, Dutta P, Titus M, Shams S, Bhosale P, Kim M, McAllister F, Bhattacharya PK. Metabolic Imaging Using Hyperpolarization for Assessment of Premalignancy. Methods Mol Biol 2435:169-180, 2022. PMID: 34993946.
- Chandra V, McAllister F, Burks JK. Cytometry of Mass for Murine Immunoprofiling. Methods Mol Biol 2435:129-137, 2022. PMID: 34993943.
- Quesada PR, Riquelme E, Burks J, Rakoski A, Sahin I, McAllister F. Assessment of the Murine Tumor Microenvironment by Multiplex Immunofluorescence. Methods Mol Biol 2435:107-127, 2022. PMID: 34993942.
- Chang K, McAllister F, Vilar E. Transcriptomic-Assisted Immune and Neoantigen Profiling in Premalignancy. Methods Mol Biol 2435:95-105, 2022. PMID: 34993941.
- Li L, Chandra V, McAllister F, Zhang Y. Mouse Models to Study Secondary Cancer Prevention. Methods Mol Biol 2435:215-223, 2022. PMID: 34993950.
- Furniss CS, Yurgelun MB, Ukaegbu C, Constantinou PE, Lafferty CC, Talcove-Berko ER, Schwartz AN, Stopfer JE, Underhill-Blazey M, Kenner B, Nelson SH, Okumura S, Law S, Zhou AY, Coffin TB, Rodriguez NJ, Uno H, Ocean AJ, McAllister F, Lowy AM, Lippman SM, Klein AP, Madlensky L, Petersen GM, Garber JE, Goggins MG, Maitra A, Syngal S. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer Prev Res (Phila) 14(11):1021-1032, 2021. e-Pub 2021. PMID: 34625409.
- Brandi G, Turroni S, McAllister F, Frega G. The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?. Int J Mol Sci 22(18), 2021. e-Pub 2021. PMID: 34576078.
- Sinha VC, Rinkenbaugh AL, Xu M, Zhou X, Zhang X, Jeter-Jones S, Shao J, Qi Y, Zebala JA, Maeda DY, McAllister F, Piwnica-Worms H. Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast. Nat Commun 12(1):5024, 2021. e-Pub 2021. PMID: 34408137.
- Singh K, Pruski M, Bland R, Younes M, Guha S, Thosani N, Maitra A, Cash BD, McAllister F, Logsdon CD, Chang JT, Bailey-Lundberg JM. Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer. Lab Invest 101(2):177-192, 2021. e-Pub 2020. PMID: 33009500.
- Rogers JE, Mizrahi JD, Xiao L, Mohindroo C, Shroff RT, Wolff R, Varadhachary GR, Javle MM, Overman M, Fogelman DR, Raghav KPS, Pant S, McAllister F. Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinoma. Cancer Med 9(15):5406-5415, 2020. e-Pub 2020. PMID: 32519420.
- Wasylishen AR, Sun C, Moyer SM, Qi Y, Chau GP, Aryal NK, McAllister F, Kim MP, Barton MC, Estrella JS, Su X, Lozano G. Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo. Sci Adv 6(32):eaba8415, 2020. e-Pub 2020. PMID: 32821827.
- Mendez R, Kesh K, Arora N, Di Martino L, McAllister F, Merchant N, Banerjee S, Banerjee S. Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer. Carcinogenesis 41(5):561-570, 2020. e-Pub 2019. PMID: 31369062.
- Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daßler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M, Looney MR, McAllister F, Rayes R, Renaud S, Rousseau S, Salvatore S, Schwartz RE, Spicer JD, Yost CC, Weber A, Zuo Y, Egeblad M. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med 217(6), 2020. PMID: 32302401.
- Dutta P, Pando SC, Mascaro M, Riquelme E, Zoltan M, Zacharias NM, Gammon ST, Piwnica-Worms D, Pagel MD, Sen S, Maitra A, Shams S, McAllister F, Bhattacharya PK. Early Detection of Pancreatic Intraepithelial Neoplasias (PanINs) in Transgenic Mouse Model by Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy. Int J Mol Sci 21(10), 2020. e-Pub 2020. PMID: 32466260.
- Singh K, Pruski MA, Polireddy K, Jones NC, Chen Q, Yao J, Dar WA, McAllister F, Ju C, Eltzschig HK, Younes M, Moran C, Karmouty-Quintana H, Ying H, Bailey JM. Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer. Oncogene 39(5):1152-1164, 2020. e-Pub 2019. PMID: 31570790.
- Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do KA, Peterson CB, Nejman D, Tzeng CD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister F. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell 178(4):795-806.e12, 2019. PMID: 31398337.
- Vreeland TJ, McAllister F, Javadi S, Prakash LR, Fogelman DR, Ho L, Varadhachary G, Aloia TA, Vauthey JN, Lee JE, Kim MP, Katz MHG, Tzeng CD. Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX. Pancreas 48(6):837-843, 2019. PMID: 31210666.
- Mork M, Quesada PR, Bannon S, Montiel MF, Fleming JB, Lynch PM, Bhutani MS, Lee JH, McAllister F. Pancreatic Cancer Early Detection and Interception in an Atypical Case of Peutz-Jeghers Syndrome. Pancreas 48(4):e29-e30, 2019. PMID: 30973470.
- Dutta P, Salzillo TC, Pudakalakatti S, Gammon ST, Kaipparettu BA, McAllister F, Wagner S, Frigo DE, Logothetis CJ, Zacharias NM, Bhattacharya PK. Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic Imaging. Cells 8(4), 2019. e-Pub 2019.
- Bannon SA, Montiel MF, Goldstein JB, Dong W, Mork ME, Borras E, Hasanov M, Varadhachary GR, Maitra A, Katz MH, Feng L, Futreal A, Fogelman DR, Vilar E, McAllister F. High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. Cancer Prev Res (Phila) 11(11):679-686, 2018. e-Pub 2018. PMID: 30274973.
- Chang K, Taggart MW, Reyes-Uribe L, Borras E, Riquelme E, Barnett RM, Leoni G, San Lucas FA, Catanese MT, Mori F, Diodoro MG, You YN, Hawk ET, Roszik J, Scheet P, Kopetz S, Nicosia A, Scarselli E, Lynch PM, McAllister F, Vilar E. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome. JAMA Oncol 4(8):1085-1092, 2018. PMID: 29710228.
- Zhang Y, Zoltan M, Riquelme E, Xu H, Sahin I, Castro-Pando S, Montiel MF, Chang K, Jiang Z, Ling J, Gupta S, Horne W, Pruski M, Wang H, Sun SC, Lozano G, Chiao P, Maitra A, Leach SD, Kolls JK, Vilar E, Wang TC, Bailey JM, McAllister F. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. Gastroenterology 155(1):210-223.e3, 2018. e-Pub 2018. PMID: 29604293.
- Unver N, McAllister F. IL-6 Family Cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets. Cytokine Growth Factor Rev 41:10-17, 2018. e-Pub 2018. PMID: 29699936.
- Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97-103, 2018. e-Pub 2017. PMID: 29097493.
- Sahin I, Zhang Y, McAllister F. Tumor Spheres Quantification with Smoothed Euclidean Distance Transform. J Mol Imaging Dyn 8(1), 2018. e-Pub 2018. PMID: 30319887.
- Bengsch F, Knoblock DM, Liu A, McAllister F, Beatty GL. CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer. Cancer Immunol Immunother 66(12):1609-1617, 2017. e-Pub 2017. PMID: 28856392.
- Bailey JM, Hendley AM, Lafaro KJ, Pruski MA, Jones NC, Alsina J, Younes M, Maitra A, McAllister F, Iacobuzio-Donahue CA, Leach SD. p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells. Oncogene 35(32):4282-8, 2016. e-Pub 2015. PMID: 26592447.
- Borras E, San Lucas FA, Chang K, Zhou R, Masand G, Fowler J, Mork ME, You YN, Taggart MW, McAllister F, Jones DA, Davies GE, Edelmann W, Ehli EA, Lynch PM, Hawk ET, Capella G, Scheet P, Vilar E. Genomic Landscape of Colorectal Mucosa and Adenomas. Cancer Prev Res (Phila) 9(6):417-27, 2016. e-Pub 2016.
- Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, Rossetti BJ, Peterson SN, Snesrud EC, Borisy GG, Lazarev M, Stein E, Vadivelu J, Roslani AC, Malik AA, Wanyiri JW, Goh KL, Thevambiga I, Fu K, Wan F, Llosa N, Housseau F, Romans K, Wu X, McAllister FM, Wu S, Vogelstein B, Kinzler KW, Pardoll DM, Sears CL. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A 111(51):18321-6, 2014. e-Pub 2014. PMID: 25489084.
- McAllister F, Pineda DM, Jimbo M, Lal S, Burkhart RA, Moughan J, Winter KA, Abdelmohsen K, Gorospe M, Acosta Ade J, Lankapalli RH, Winter JM, Yeo CJ, Witkiewicz AK, Iacobuzio-Donahue CA, Laheru D, Brody JR. dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trial. Cancer Biol Ther 15(6):688-98, 2014. e-Pub 2014. PMID: 24618665.
- McAllister F, Bailey JM, Alsina J, Nirschl CJ, Sharma R, Fan H, Rattigan Y, Roeser JC, Lankapalli RH, Zhang H, Jaffee EM, Drake CG, Housseau F, Maitra A, Kolls JK, Sears CL, Pardoll DM, Leach SD. Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer Cell 25(5):621-37, 2014. PMID: 24823639.
- Bailey JM, Alsina J, Rasheed ZA, McAllister FM, Fu YY, Plentz R, Zhang H, Pasricha PJ, Bardeesy N, Matsui W, Maitra A, Leach SD. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology 146(1):245-56, 2014. e-Pub 2013. PMID: 24096005.
- Wang YJ, McAllister F, Bailey JM, Scott SG, Hendley AM, Leach SD, Ghosh B. Dicer is required for maintenance of adult pancreatic acinar cell identity and plays a role in Kras-driven pancreatic neoplasia. PLoS One 9(11):e113127, 2014. e-Pub 2014. PMID: 25405615.
- Laheru D, Shah P, Rajeshkumar NV, McAllister F, Taylor G, Goldsweig H, Le DT, Donehower R, Jimeno A, Linden S, Zhao M, Song D, Rudek MA, Hidalgo M. Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer. Invest New Drugs 30(6):2391-9, 2012. e-Pub 2012. PMID: 22547163.
- Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD, Stanger BZ. EMT and dissemination precede pancreatic tumor formation. Cell 148(1-2):349-61, 2012. PMID: 22265420.
- Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15(9):1016-22, 2009. e-Pub 2009. PMID: 19701202.
- Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14(3):275-81, 2008. e-Pub 2008. PMID: 18264110.
- McKinley L, Logar AJ, McAllister F, Zheng M, Steele C, Kolls JK. Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J Immunol 177(9):6215-26, 2006. PMID: 17056551.
- McAllister F, Ruan S, Steele C, Zheng M, McKinley L, Ulrich L, Marrero L, Shellito JE, Kolls JK. CXCR3 and IFN protein-10 in Pneumocystis pneumonia. J Immunol 177(3):1846-54, 2006. PMID: 16849496.
- Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F, Hishinuma T, Goto J, Lotze MT, Kolls JK, Sasaki H. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 175(9):6177-89, 2005. PMID: 16237115.
- McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, Finder JD, Pilewski JM, Carreno BM, Goldman SJ, Pirhonen J, Kolls JK. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 175(1):404-12, 2005. PMID: 15972674.
- McAllister F, Steele C, Zheng M, Young E, Shellito JE, Marrero L, Kolls JK. T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice. J Immunol 172(2):1132-8, 2004. PMID: 14707088.
Invited Articles
- Riquelme E, Maitra A, McAllister F. Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling. Cancer Discov 8(4):386-388, 2018. PMID: 29610286.
- McAllister F, Montiel MF, Uberoi GS, Uberoi AS, Maitra A, Bhutani MS. Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer. Gastroenterol Hepatol (N Y) 13(5):268-275, 2017. PMID: 28656024.
- Roeser JC, Leach SD, McAllister F. Emerging strategies for cancer immunoprevention. Oncogene 34(50):6029-39, 2015. e-Pub 2015. PMID: 26364615.
- McAllister F, Kolls JK. Th17 cytokines in non-melanoma skin cancer. Eur J Immunol 45(3):692-4, 2015. PMID: 25655439.
- McAllister F, Leach SD. Targeting IL-17 for pancreatic cancer prevention. Oncotarget 5(20):9530-1, 2014. PMID: 25393980.
- McAllister F, Housseau F, Sears CL. Microbiota and immune responses in colon cancer: more to learn. Cancer J 20(3):232-6, 2014. PMID: 24855013.
- Zhang Y, McAllister F, Pasca di Magliano M. Immune cells in pancreatic cancer: Joining the dark side. Oncoimmunology 3:e29125, 2014. e-Pub 2014. PMID: 25083330.
- Zhong W, Kolls JK, Chen H, McAllister F, Oliver PD, Zhang Z. Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease. Front Biosci 13:1654-64, 2008. e-Pub 2008. PMID: 17981657.
- Dubin PJ, McAllister F, Kolls JK. Is cystic fibrosis a TH17 disease?. Inflamm Res 56(6):221-7, 2007. PMID: 17607545.
Editorials
- McAllister F, Mantegazza A, Garzón F, Rotbaum V, Remondino G, Vazquez Larsson M, Geffner J, Rabinovich GA, Bover L. [Use of convalescent plasma for COVID-19 treatment. History and evidence]. Medicina (B Aires) 80 Suppl 3:82-86, 2020. PMID: 32658853.
Abstracts
- Zhang Y, Sahin I, Gupta S, Maitra A, Bailey J and McAllister F. IL-17-secreting cells promote pancreatic stemness. Proceedings of the American Association for Cancer Research (AACR), 2016.
- Zhang Y, Sahin I, Bailey J and McAllister F. Role of TH17 cells in promoting stemness. PanCAN Meeting, 2015.
- McAllister F, Bailey JM, Roeser JC, Wick E, Sears C, Kolls JK, Drake C, Pardoll DM, Leach SD. TH17 cells in Health and Disease. Keystone Symposia(AQ2):231, 2012.
- McAllister F, Kelly L, Panelli M, Sanders C, ButterfieldL, Kirkwood J. Th17 cells are recruited to metastatic lymph nodes in patients with Stage IIIB melanoma after High-Dose IFNa2b. Proceedings of the American Association for Cancer Research (AACR), 2009.
- McAllister F, Steele C, Zheng M, Shellito JE, Kolls JK. In vitro effector activity of Pneumocystis murina-specific T-cytotoxic-1 CD8+ T cells: role of granulocyte-macrophage colony-stimulating factor. Infect Immun 73(11):7450-7, 2005. PMID: 16239546.
- McAllister F, Kolls JK. IL-17A and IL17F signaling in human bronchial epithelial cells. Quantification of the upstream molecule, IL-23, in sputum from cystic fibrosis patients. Pediatric Pulmonology, 2005.
- McAllister F, Henry A, Kreindler JL, Dubin P, Ulrich L, Steele C, Finder J, Pilewski J, Carreno B, Goldman SJ, Pirhonen J, Kolls JK. Augmented IL-17 in sputum from patients with Cystic Fibrosis. Keystone Publishing, Cytokines, Disease, and Therapeutics Intervention Cytokine, 2005.
- McAllister F, Shellito J, Steele C, Kolls JK. In Vitro Generation of Polarized Pneumocystis Carinii-Specific CD8+ T Cells Effector Populations. Proceedings of the American Thoracic Society 2(A):A683, 2005.
- McAllister F, Steele C, Henry A, Ulrich L, Pilewski J, Carreno B, Goldman S, Kolls JK. Increased Expression of IL-23 and IL-17A/ IL-17F in Sputum from Patients with Cystic Fibrosis. Proceedings of the American Thoracic Society 2(A):A102, 2005.
- McAllister F, Steele C, Henry A, Ulrich L, Pilewski J, Carreno B, Goldman S, Kolls JK. IL-17A and IL-17F Signaling and Pro-Inflammatory Responses in Human Bronchial Epithelial Cells. Proceedings of the American Thoracic Society 2(A):A109, 2005.
- McAllister F, Shellito J, Steele C, Kolls JK. IP-10 Effector Activity Against Pneumocystis Carinii. Proceedings of the American Thoracic Society. Proceedings of the American Thoracic Society 2(A):A869, 2005.
- McAllister F, Henry A, Pilewski J, Kolls JK. IL-17 pro-inflammatory responses in Human Bronchial Epithelial cells. Pediatric Pulmonology, 2004.
- Steele C, Finder J, McAllister F, Kolls JK. Analysis of Inflammatory biomarkers in bronchoalveolar lavage fluid from cystic fibrosis patients using Luminex technology. Pediatric Pulmonology, 2004.
- McAllister F, Steele C, Zheng M, Young E, Shellito J, Marrero L, Kolls JK. CD8+T cells against Pneumocystis. Proceedings of the American Thoracic Society, 2004.
- McAllister F, Steele C, Zheng M, Shellito J, Marrero L, Kolls JK. Role of CD8+T cells in host defense against Pneumocystis in mice. FASEB, 2004.
Grant & Contract Support
| Title: | Start-up funds |
| Funding Source: | MDACC |
| Role: | Principal Investigator-MDACC |
| Title: | Use of Hyperpolarization to detect Pancreatic Intraepithelial Neoplasias |
| Funding Source: | American Association for Cancer Research (AACR) |
| Role: | Co-Principal Investigator |
| Title: | Influence of the gut microbiome on pancreatic cancer through modulation of the immune system |
| Funding Source: | AGA-Bernard Lee Schwartz Research Scholar Award |
| Role: | Principal Investigator |
| Title: | SUC2-Intercepting Pancreatic Cancer in High Risk Cohorts |
| Funding Source: | SU2C |
| Role: | Co-Investigator |
| Title: | Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Manipulating the gut and tumor microbiome to induce anti-tumoral immune responses against pancreatic cancer |
| Funding Source: | Emerson Collective Award |
| Role: | Principal Investigator |
| Title: | Manipulating the gut and tumor microbiome to improve pancreatic cancer outcomes |
| Funding Source: | Emerson Collective Award |
| Role: | Principal Investigator |
| Title: | Developing Imaging Biomarkers for Immunotherapy Resistance In Vivo |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-Investigator |
| Title: | Targeting NETosis to Prevent Liver Metastasis Niche Formation |
| Funding Source: | UTMDACC GI SPORE DRP Program |
| Role: | Principal Investigator |
| Title: | Preclinical PREVENT Cancer Program: Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-Principal Investigator |
Patient Reviews
CV information above last modified November 13, 2024